paper
propos
quarantinesusceptibleexposedinfectiousresist
qseir
model
consid
unpreced
strict
quarantin
measur
almost
whole
china
resist
epidem
estim
model
paramet
publish
inform
statist
method
stochast
simul
found
paramet
achiev
best
simul
test
result
next
stage
involv
quantit
predict
futur
epidem
develop
base
differ
contain
strategi
qseir
model
focus
sensit
outcom
differ
paramet
choic
mainland
china
main
result
follow
strict
quarantin
measur
retain
peak
valu
confirm
case
would
rang
peak
date
would
expect
rang
februari
februari
epidem
would
control
end
date
would
period
august
septemb
probabl
predict
peak
date
day
ahead
real
date
predict
error
peak
valu
estim
much
closer
observ
valu
compar
publish
studi
sensit
analysi
indic
quarantin
measur
vaccin
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
medrxiv
preprint
effect
contain
strategi
control
epidem
follow
measur
increas
cure
rate
like
find
special
medicin
longterm
simul
result
sensit
analysi
mainland
china
show
qseir
model
stabl
empir
valid
suggest
qseir
model
appli
predict
develop
trend
epidem
region
countri
world
mainland
china
quarantin
measur
ca
nt
relax
end
march
china
fulli
resum
product
appropri
antiepidem
measur
begin
earli
april
result
studi
also
impli
countri
face
epidem
outbreak
act
decis
take
time
quarantin
measur
though
may
neg
shortterm
public
econom
consequ
late
decemb
atyp
pneumonia
case
caus
viru
call
first
report
confirm
wuhan
china
although
initi
case
consid
associ
huanan
seafood
market
sourc
still
unknown
confirm
case
increas
exponenti
speed
januari
januari
mainland
china
far
exceed
sar
epidem
see
figur
japan
singapor
rank
top
figur
case
report
unit
state
america
transmiss
least
geograph
distribut
figur
seem
higher
broader
initi
expect
horton
compar
sarscov
mortal
merscov
mortal
appear
less
virul
point
except
elderli
underli
health
condit
tabl
confirm
subject
humantohuman
transmiss
contagi
basic
reproduct
number
estim
research
institut
rang
tabl
valu
slightli
higher
sar
epidem
much
higher
influenza
ebola
incub
day
wuhan
citi
day
mean
day
fan
et
al
averag
durat
confirm
stage
cure
death
day
nationwid
report
accord
guan
et
al
long
incub
period
associ
larg
number
patient
mild
symptom
increas
difficulti
prevent
control
epidem
likelihood
travelrel
risk
diseas
spread
note
bogoch
et
al
cao
et
al
wherein
indic
potenti
region
global
spread
leung
et
al
epidem
broke
eve
spring
festiv
largescal
popul
movement
gather
peopl
aggrav
epidem
outbreak
local
govern
adopt
seri
unpreced
mitig
polici
place
contain
spread
epidem
major
local
public
emerg
start
categori
class
respons
health
incid
posit
diagnos
case
either
quarantin
put
form
selfquarantin
home
gan
http
lipsitch
et
al
pastorsatorra
seir
model
flow
peopl
four
state
suscept
expos
e
infect
resist
r
variabl
repres
number
peopl
group
assum
averag
number
expos
case
gener
one
infect
person
paramet
similar
basic
reproduct
number
thought
expect
number
case
directli
gener
one
case
popul
individu
suscept
infect
consid
protect
measur
taken
smaller
basic
reproduct
number
tabl
individu
expos
state
type
e
probabl
chang
individu
infect
state
type
individu
infect
state
type
chang
cure
state
type
r
probabl
death
state
type
f
probabl
per
unit
time
contrast
tradit
seir
model
propos
quarantinesusceptibleexposedinfectiousresist
qseir
model
consid
unpreced
strict
quarantin
measur
mainland
china
resist
epidem
paramet
design
repres
ratio
peopl
restrict
specif
area
chanc
contact
viru
special
period
vari
accord
strength
prevent
control
measur
epidem
make
model
accord
realiti
contrast
standard
seir
model
ad
two
paramet
ratio
peopl
vaccin
time
natur
mortal
popul
region
time
figur
valu
close
relat
viru
incub
infecti
period
depend
treatment
level
patient
health
statu
assum
viru
incub
period
day
durat
confirm
stage
cure
death
day
base
nationwid
inform
guan
et
al
fan
et
al
model
ordinari
differenti
equat
model
describ
follow
equat
df
equat
razum
becher
isol
wuhan
januari
stricter
requir
data
statist
provis
detect
level
data
reliabl
estim
model
paramet
revers
qseir
model
equat
calcul
see
tabl
equat
obtain
note
found
tabl
obvious
incorrect
reason
mainli
bias
data
earli
stage
cao
et
al
delet
data
calcul
averag
median
varianc
rest
valu
four
paramet
first
step
step
delet
valu
time
column
averag
step
calcul
averag
median
varianc
rest
valu
four
paramet
see
authorfund
grant
medrxiv
licens
display
preprint
perpetu
set
errck
mean
ab
e
mean
ab
mean
ab
r
mean
ab
f
equat
first
calcul
averag
absolut
differ
real
data
simul
valu
e
r
f
kth
simul
ad
fouraverag
valu
set
januari
begin
date
simul
initi
valu
variabl
set
date
tabl
set
simul
period
day
input
best
paramet
found
matlab
program
qseir
model
present
result
shown
figur
result
show
probabl
peak
valu
februari
june
valu
would
juli
number
would
smaller
august
would
smaller
impli
would
essenti
end
march
e
would
week
later
march
number
e
would
mean
epidem
would
total
control
sinc
day
new
infect
peopl
would
appear
cumul
confirm
case
mainland
china
estim
cumul
number
death
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
estim
consid
estim
error
errc
peak
valu
would
rang
peak
date
would
expect
rang
februari
februari
end
date
would
rang
august
septemb
period
epidem
would
total
control
furthermor
exist
studi
seldom
provid
estim
durat
epidem
effect
differ
contain
strategi
mainland
china
region
level
wu
et
al
conclud
guangdong
provinc
epidem
would
total
control
mid
late
march
cumul
confirm
case
guangdong
rank
second
among
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
would
e
r
f
chang
valu
paramet
vari
begin
date
januari
simul
chang
conduct
sensit
analys
term
impact
index
one
one
figur
tabl
show
larger
valu
higher
peak
valu
index
earlier
peak
time
increas
sensit
coeffici
index
decreas
progress
sensit
coeffici
index
biggest
increas
confirm
case
observ
figur
tabl
result
indic
quarantin
measur
vaccin
yet
avail
effect
contain
strategi
control
epidem
figur
tabl
show
greater
valu
smaller
peak
valu
index
peak
date
sensit
chang
increas
confirm
case
decreas
decreas
addit
confirm
case
could
expect
averag
absolut
sensit
coeffici
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
rank
second
third
five
paramet
tabl
show
improv
rate
cure
develop
special
medicin
second
effect
measur
begin
date
simul
chang
januari
januari
februari
valu
variabl
tabl
togeth
estim
valu
paramet
tabl
qseir
program
show
main
result
start
januari
figur
compar
baselin
peak
valu
index
increas
peak
date
end
date
would
day
day
ahead
figur
tabl
result
mean
simul
result
sensit
initi
start
date
qseir
model
system
stabl
due
downward
pressur
economi
enterpris
resum
work
one
anoth
complianc
requir
epidem
prevent
control
newli
confirm
ed
case
decreas
day
day
sinc
februari
outbreak
gradual
brought
u
nder
control
peopl
began
relax
vigil
began
travel
went
wi
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
paper
propos
qseir
model
consid
unpreced
strict
quarantin
measur
fit
epidem
situat
mainland
china
paramet
estim
critic
part
use
kind
seir
model
predict
trend
epidem
cao
et
al
estim
model
paramet
revers
qseir
model
publish
inform
statist
method
stochast
simul
experi
found
paramet
achiev
best
simul
test
result
applic
verifi
method
effect
paper
predict
peak
number
peak
date
confirm
case
also
provid
estim
sensit
paramet
qseir
durat
epidem
effect
differ
contain
strategi
time
longterm
simul
result
sensit
analysi
mainland
china
show
qseir
model
stabl
empir
valid
suggest
qseir
model
appli
predict
develop
trend
epidem
region
countri
world
qseir
model
paramet
dynam
chang
day
paramet
estim
import
part
kind
seir
model
cao
et
al
paper
illustr
method
gener
paramet
estim
given
data
limit
estim
constant
valu
error
simul
test
best
result
time
stochast
simul
within
statist
rang
appli
valu
predict
obtain
better
result
exist
research
improv
data
qualiti
data
variabl
paramet
estim
forecast
accuraci
model
could
enhanc
vaccin
research
develop
cycl
rel
long
research
product
largescal
product
promot
take
month
seem
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
vaccin
appli
largescal
quantiti
end
august
howev
spread
serious
countri
region
world
also
possibl
return
china
march
confirm
case
report
countriesterritori
area
henc
imper
develop
vaccin
specif
drug
promot
mani
countri
technic
resourc
conduct
necessari
highlevel
research
appear
import
appropri
quarantin
measur
retain
mainland
china
quarantin
measur
relax
end
march
china
fulli
resum
product
appropri
antiepidem
measur
begin
earli
april
result
studi
also
impli
countri
face
epidem
outbreak
act
decis
take
time
quarantin
measur
though
may
neg
shortterm
public
econom
consequ
editori
liu
x
l
design
qseir
model
gave
method
estim
paramet
compil
matlab
program
got
result
wrote
draft
manuscript
hew
g
suggest
make
sensit
analysi
paramet
estim
effect
differ
contain
strategi
edit
manuscript
wang
explain
result
provid
polici
implic
qin
h
xiang
x
zheng
li
x
f
collect
data
refer
analyz
data
four
made
equal
contribut
paper
authorfund
grant
medrxiv
licens
display
preprint
perpetu
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
authorfund
grant
medrxiv
licens
display
preprint
perpetu
tabl
peak
valu
peak
date
index
chang
sensit
coeffici
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
authorfund
grant
medrxiv
licens
display
preprint
perpetu
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
